REHANA RAB: Open Payments
NPI 1568806271 · PATERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,170 in 45 payments from 13 companies in 2025. Trend: 2023 $3,576 · 2024 $2,521 · 2025 $2,170
Food & beverage: $2,170
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $845 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $504 |
| Amgen Inc. | 3 | $265 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $127 |
| Viatris Specialty LLC | 1 | $122 |
| Dexcom, Inc. | 4 | $89 |
| ABBVIE INC. | 5 | $85 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| Novo Nordisk Inc | 1 | $20 |
Products named: JARDIANCE, BREZTRI, FASENRA, REPATHA, Kerendia, YUPELRI, Dexcom G6 Transmitter, AIRSUPRA.
Industry payments across NJ — which companies pay providers there.
